JP2016518109A5 - - Google Patents

Download PDF

Info

Publication number
JP2016518109A5
JP2016518109A5 JP2016501590A JP2016501590A JP2016518109A5 JP 2016518109 A5 JP2016518109 A5 JP 2016518109A5 JP 2016501590 A JP2016501590 A JP 2016501590A JP 2016501590 A JP2016501590 A JP 2016501590A JP 2016518109 A5 JP2016518109 A5 JP 2016518109A5
Authority
JP
Japan
Prior art keywords
microvesicles
fluid
isolated
tissue
promote
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016501590A
Other languages
English (en)
Japanese (ja)
Other versions
JP6562897B2 (ja
JP2016518109A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/024629 external-priority patent/WO2014159662A1/en
Publication of JP2016518109A publication Critical patent/JP2016518109A/ja
Publication of JP2016518109A5 publication Critical patent/JP2016518109A5/ja
Priority to JP2019105087A priority Critical patent/JP7405389B2/ja
Application granted granted Critical
Publication of JP6562897B2 publication Critical patent/JP6562897B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016501590A 2013-03-13 2014-03-12 細胞培養上清および生体液からの微小胞の単離および精製のための方法 Active JP6562897B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019105087A JP7405389B2 (ja) 2013-03-13 2019-06-05 細胞培養上清および生体液からの微小胞の単離および精製のための方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361778591P 2013-03-13 2013-03-13
US61/778,591 2013-03-13
PCT/US2014/024629 WO2014159662A1 (en) 2013-03-13 2014-03-12 Method for isolation and purification of microvesicles from cell culture supernatants and biological fluids

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019105087A Division JP7405389B2 (ja) 2013-03-13 2019-06-05 細胞培養上清および生体液からの微小胞の単離および精製のための方法

Publications (3)

Publication Number Publication Date
JP2016518109A JP2016518109A (ja) 2016-06-23
JP2016518109A5 true JP2016518109A5 (cg-RX-API-DMAC7.html) 2017-04-13
JP6562897B2 JP6562897B2 (ja) 2019-08-21

Family

ID=51625222

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016501590A Active JP6562897B2 (ja) 2013-03-13 2014-03-12 細胞培養上清および生体液からの微小胞の単離および精製のための方法
JP2019105087A Active JP7405389B2 (ja) 2013-03-13 2019-06-05 細胞培養上清および生体液からの微小胞の単離および精製のための方法
JP2022027857A Active JP7417301B2 (ja) 2013-03-13 2022-02-25 細胞培養上清および生体液からの微小胞の単離および精製のための方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2019105087A Active JP7405389B2 (ja) 2013-03-13 2019-06-05 細胞培養上清および生体液からの微小胞の単離および精製のための方法
JP2022027857A Active JP7417301B2 (ja) 2013-03-13 2022-02-25 細胞培養上清および生体液からの微小胞の単離および精製のための方法

Country Status (13)

Country Link
US (4) US10500231B2 (cg-RX-API-DMAC7.html)
EP (3) EP2972193B1 (cg-RX-API-DMAC7.html)
JP (3) JP6562897B2 (cg-RX-API-DMAC7.html)
CN (2) CN105209881B (cg-RX-API-DMAC7.html)
AU (4) AU2014244618A1 (cg-RX-API-DMAC7.html)
CA (1) CA2906502A1 (cg-RX-API-DMAC7.html)
DK (2) DK2972193T3 (cg-RX-API-DMAC7.html)
ES (2) ES2778098T3 (cg-RX-API-DMAC7.html)
FI (1) FI3677271T3 (cg-RX-API-DMAC7.html)
HU (2) HUE062348T2 (cg-RX-API-DMAC7.html)
PL (2) PL3677271T3 (cg-RX-API-DMAC7.html)
PT (2) PT3677271T (cg-RX-API-DMAC7.html)
WO (1) WO2014159662A1 (cg-RX-API-DMAC7.html)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10640464B2 (en) 2011-01-03 2020-05-05 The William M. Yarbrough Foundation Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
US12558316B2 (en) 2013-03-13 2026-02-24 University Of Miami Methods and compositions for the treatment of epidermolysis bullosa
AU2014244618A1 (en) 2013-03-13 2015-10-08 University Of Miami Method for isolation and purification of microvesicles from cell culture supernatants and biological fluids
US11160904B2 (en) 2017-05-09 2021-11-02 Vivex Biologies Group, Inc. Biological composition in a protectant shroud and methods
US20180325830A1 (en) 2017-05-09 2018-11-15 Vivex Biomedical, Inc. Coated biological composition
US9687511B2 (en) * 2015-03-06 2017-06-27 Vivex Biomedical, Inc. Acellular biologic composition and method of manufacture
WO2016145330A1 (en) * 2015-03-11 2016-09-15 Atta Behfar Exosome delivery technology
WO2016149358A1 (en) * 2015-03-16 2016-09-22 Duncan Ross Method of treatment comprising membrane-enclosed vesicle
HRP20230865T1 (hr) * 2015-07-31 2023-11-10 Exotropin, Llc Kompozicije egzosoma i postupci za njihovu pripremu i primjenu za reguliranje i kondicioniranje kože i kose
KR102418785B1 (ko) 2015-09-25 2022-07-08 (주)프로스테믹스 식물 착즙물 유래 세포 외 소포체를 포함하는 피부 개선 및 탈모 방지용 조성물
KR102475127B1 (ko) * 2015-09-30 2022-12-07 (주)아모레퍼시픽 인삼 유래의 엑소좀 유사 베지클을 포함하는 탈모 방지 또는 육모 촉진용 조성물
WO2017117585A1 (en) * 2015-12-30 2017-07-06 The Regents Of The University Of California Methods for enhanced production and isolation of cell-derived vesicles
JP2019505590A (ja) * 2016-01-19 2019-02-28 ジェイ. サイレン、マッティ 癌の予防、処置および/または緩和における使用のための方法および組成物
KR102475129B1 (ko) * 2016-03-22 2022-12-07 (주)아모레퍼시픽 인삼 유래의 엑소좀 유사 베지클을 유효성분으로 포함하는 항노화용 조성물
WO2018039100A2 (en) * 2016-08-23 2018-03-01 Albert Einstein College Of Medicine, Inc. Stem cell-produced microvesicles for treating tendon pathologies
WO2018130554A1 (en) * 2017-01-11 2018-07-19 Paracelsus Medizinische Privatuniversität Salzburg - Privatstiftung Mesenchymal stem cell-derived extracellular vesicles and their medical use
JP2020528766A (ja) * 2017-07-26 2020-10-01 ロゼッタ エクソソーム 陽イオンを利用した細胞外小胞体の分離方法
ES2968625T3 (es) * 2017-07-27 2024-05-13 Univ Cornell Un método para la fijación y retención de vesículas extracelulares, vesículas extracelulares fijadas y un método para diagnosticar una enfermedad
CN111182890A (zh) * 2017-09-22 2020-05-19 迈阿密大学 用于治疗大疱性表皮松解症的方法和组合物
US11471559B2 (en) 2017-11-20 2022-10-18 Vivex Biologics Group, Inc. Bioenergetic bone
US11660271B2 (en) 2018-01-29 2023-05-30 Forever Labs, Inc. System and method for isolating extracellular vesicles
CN108414334A (zh) * 2018-02-23 2018-08-17 中山大学附属第医院 一种从精液中分离提纯外泌体的方法
US11752175B2 (en) 2018-09-21 2023-09-12 Cornell University Compositions and methods for glaucoma
AU2020228303B2 (en) * 2019-02-28 2025-09-18 Merakris Therapeutics Llc Amniotic fluid-derived extracellular vesicles and uses thereof for wound healing
IT201900024580A1 (it) * 2019-12-18 2021-06-18 Consiglio Nazionale Ricerche Vescicole extracellulari da microalghe
CN113384597A (zh) * 2020-03-13 2021-09-14 西比曼生物科技(上海)有限公司 含人体细胞衍生的细胞膜外囊泡的雾化吸入制剂、制法及其应用
CN111893093A (zh) * 2020-08-03 2020-11-06 沈阳三禾生物科技有限公司 一种脐带间充质干细胞来源的超微因子的制备方法
AU2021327376A1 (en) 2020-08-21 2023-04-20 University Of Miami Compositions and methods of treatment using microvesicles from bone marrow-derived mesenchymal stem cells
WO2022080461A1 (ja) * 2020-10-16 2022-04-21 富士フイルム和光純薬株式会社 細胞外小胞の産生用培地、培地キット、添加剤及び細胞外小胞の産生方法
CN114081900B (zh) * 2021-02-24 2024-11-22 济宁医学院附属医院 间充质干细胞来源的纳米微囊泡在制备治疗子痫前期的药物中的应用
CN115212230B (zh) * 2021-04-21 2024-12-27 时比曼生物科技(上海)有限公司 含有干细胞胞外囊泡的药物组合物及其在呼吸道炎症治疗中的应用
EP4511045A1 (en) 2022-04-19 2025-02-26 University of Miami Compositions comprising microvesicles for use in the prevention and treatment of graft versus host disease
KR20240028586A (ko) * 2022-08-24 2024-03-05 (주) 테라베스트 인간 세포 유래 미세소포체 및 히알루론산 또는 콜라겐을 포함하는 조성물 및 이의 용도
CN116898781B (zh) * 2023-02-07 2025-08-15 中国中医科学院中医基础理论研究所 大麦苗外泌体在制备具有抗衰老修护作用的产品中的应用

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9206861D0 (en) 1992-03-28 1992-05-13 Univ Manchester Wound healing and treatment of fibrotic disorders
EP0841945B1 (en) 1995-08-03 2006-03-08 Rijksuniversiteit te Leiden Cell derived antigen presenting vesicles
US6372779B1 (en) 1997-12-29 2002-04-16 Ortho Pharmaceutical Corporation Anti-inflammatory compounds
MY132496A (en) 1998-05-11 2007-10-31 Vertex Pharma Inhibitors of p38
US6413556B1 (en) 1999-01-08 2002-07-02 Sky High, Llc Aqueous anti-apoptotic compositions
US6372494B1 (en) * 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
GB9927320D0 (en) 1999-11-18 2000-01-12 Chiron Spa Exosome separation
AU2002246855B2 (en) 2000-10-23 2005-12-22 Smithkline Beecham Corporation Novel compounds
KR20030088022A (ko) * 2000-11-30 2003-11-15 스템론 인크. 단리된 동종접합 간세포, 그로부터 유래된 분화 세포 및이들을 제조 및 사용하기 위한 물질 및 방법
GB0117583D0 (en) 2001-07-19 2001-09-12 Astrazeneca Ab Novel compounds
KR100519384B1 (ko) 2002-08-13 2005-10-06 (주)누백스 유전자 이입을 이용한 엑소좀의 제조방법 및 상기 엑소좀의 용도
US7144999B2 (en) 2002-11-23 2006-12-05 Isis Pharmaceuticals, Inc. Modulation of hypoxia-inducible factor 1 alpha expression
US8021847B2 (en) 2004-06-02 2011-09-20 Proxy Life Science Holdings, Inc. Microvesicle-based compositions and methods
WO2005121369A2 (en) * 2004-06-02 2005-12-22 Sourcepharm, Inc. Rna-containing microvesicles and methods therefor
WO2006007529A2 (en) 2004-07-01 2006-01-19 University Of Pittsburgh Of The Commonwealth System For Higher Education Immunosuppressive exosomes
AU2006202209B2 (en) 2005-05-27 2011-04-14 Lifescan, Inc. Amniotic fluid derived cells
US8637005B2 (en) 2005-11-07 2014-01-28 Amorcyte, Inc. Compositions and methods of vascular injury repair
ES2880460T3 (es) 2006-03-09 2021-11-24 Aethlon Medical Inc Eliminación extracorpórea de partículas microvesiculares
US9085778B2 (en) 2006-05-03 2015-07-21 VL27, Inc. Exosome transfer of nucleic acids to cells
ES2425387T3 (es) 2006-07-13 2013-10-15 The Ohio State University Research Foundation Mir-106a para diagnosticar adenocarcinoma de colon de pronóstico de supervivencia pobre
EP1939218A1 (en) * 2006-12-29 2008-07-02 Thrombotargets Europe, S.L. Microvesicles derived from recombinant yeast having haemostatic activities and uses thereof
AU2008226974B2 (en) 2007-03-09 2013-08-15 Merck Sharp & Dohme Llc Papillomavirus vaccine compositions
US8053186B2 (en) 2007-06-15 2011-11-08 The Ohio State University Research Foundation Oncogenic ALL-1 fusion proteins for targeting Drosha-mediated microRNA processing
GB2459228B (en) 2007-07-25 2012-06-20 Univ Louisville Res Found Exosome-associated microrna as a diagnostic marker
US20100255514A1 (en) * 2007-08-16 2010-10-07 The Royal Institution For The Advancement Of Learning/Mcgill University Tumor cell-derived microvesicles
JP5719171B2 (ja) * 2007-10-15 2015-05-13 フレゼニウス メディカル ケア ドイッチェランド ゲゼルシャフト ミット ベシュレンクテル ハフツング 内皮細胞移植、特に膵島移植による糖尿病の処置におけるアジュバント活性を有する医薬を調製するための微小胞(mv)の使用、および関連方法
CN101854941B (zh) * 2007-10-29 2013-03-27 弗雷森纽斯医疗护理德国有限责任公司 衍生自干细胞的微泡(MVs)用于制备用于受损或损伤组织或器官的内皮/上皮再生的药物的用途、以及相关体外和体内方法
NZ586497A (en) 2008-01-04 2012-07-27 Lydac Neuroscience Ltd Microvesicles
US20120058492A1 (en) 2008-01-25 2012-03-08 Hansabiomed Ou Method and a Kit To Detect Malignant Tumors and Provide a Prognosis
US8617806B2 (en) 2008-01-25 2013-12-31 Hansabiomed Ou Method to measure and characterize microvesicles in the human body fluids
AU2009212543B2 (en) * 2008-02-01 2015-07-09 The General Hospital Corporation Use of microvesicles in diagnosis, prognosis and treatment of medical diseases and conditions
PT2254586E (pt) * 2008-02-22 2015-05-18 Agency Science Tech & Res Partículas de células estaminais mesenquimais
FR2928926B1 (fr) 2008-03-18 2015-08-21 Centre Nat Rech Scient Polynucleotides et polypeptides chimeriques permettant la secretion d'un polypeptide d'interet en association avec des exosomes et leur utilisation pour la production de compositions immunogenes
CN102065870B (zh) * 2008-04-16 2014-11-19 比奥根艾迪克Ma公司 使用聚亚烷基二醇和过渡金属分离生物大分子的方法
US10545149B2 (en) 2008-10-06 2020-01-28 Morehouse School Of Medicine Detection of HIV-related proteins in urine
AU2009308152B2 (en) 2008-10-21 2015-05-21 The General Hospital Corporation Cell transplantation
EP2350320A4 (en) 2008-11-12 2012-11-14 Caris Life Sciences Luxembourg Holdings METHOD AND SYSTEMS FOR USE OF EXOSOMES FOR THE DETERMINATION OF PHENOTYPES
BRPI1007321A2 (en) 2009-01-15 2018-07-10 Laboratory Corporation Of America Holdings methods for measuring and / or quantifying the presence and / or amount of her-3 or her-3 in a complex in a patient sample, and to determine if an individual with cancer is likely to respond to treatment with a targeted therapy. and antibody.
CN107252489A (zh) 2009-04-13 2017-10-17 法国健康和医学研究院 Hpv颗粒及其用途
PT2419144T (pt) 2009-04-17 2019-09-16 Univ Oxford Innovation Ltd Composição para a administração de material genético
BRPI0900815A2 (pt) 2009-04-23 2010-12-28 Sociedade Benef Israelita Bras Hospital Albert Einstein método para isolamento de exossomos a partir de soluções biológicas utilizando nanopartìculas de óxido de ferro
AU2010268367B2 (en) 2009-07-02 2016-10-20 Ith Immune Therapy Holdings Ab Exosome based treatment of cancer
DK2454588T3 (en) * 2009-07-16 2015-09-28 Gen Hospital Corp Nucleic acid
DK2521918T3 (en) 2010-01-08 2015-06-29 Cavadis B V DETERMINATION OF EXOSOMAL BIOMARKETS FOR PREVENTION OF CARDIOVASCULAR EVENTS
US20120315324A1 (en) 2010-02-05 2012-12-13 University Of Louisville Research Foundation, Inc. Exosomal compositions and methods for the treatment of disease
US9066971B2 (en) 2010-07-01 2015-06-30 Postech Academy-Industry Foundation Method for treating and diagnosing cancer by using cell-derived microvesicles
EP2603592A2 (en) 2010-08-13 2013-06-19 The University Court of the University of Glasgow Therapeutic uses of microvesicles and related micrornas
US20120053976A1 (en) 2010-08-31 2012-03-01 Xerox Corporation System and method for determining whether service costs can be reduced
US20120093885A1 (en) * 2010-10-18 2012-04-19 Northwestern University Therapeutic vesicles
JP5911874B2 (ja) * 2010-10-18 2016-04-27 エージェンシー フォー サイエンス,テクノロジー アンド リサーチ 発毛を促進又は増強するためのエキソソームの使用
SG183579A1 (en) 2011-02-11 2012-09-27 Agency Science Tech & Res Methods of detecting therapeutic exosomes
WO2012126531A1 (en) 2011-03-24 2012-09-27 Cavadis B.V. Method for diagnosing acute coronary syndrome (acs)
WO2012110253A2 (en) 2011-02-18 2012-08-23 Cavadis B.V. Exosomal biomarkers for cardiovascular events
WO2012110099A1 (en) 2011-02-18 2012-08-23 Cavadis B.V. Determination of exosomal biomarkers for predicting cardiovascular events
US9816998B2 (en) 2011-04-01 2017-11-14 Cornell University Circulating exosomes as diagnostic/prognostic indicators and therapeutic targets of melanoma and other cancers
EP3210662A1 (en) 2011-06-08 2017-08-30 Agency For Science, Technology And Research Purification of biological products by constrained cohydration chromatography
WO2013014669A1 (en) 2011-07-24 2013-01-31 Carmel-Haifa University Economic Corp. Lactoferrin fragments and use thereof
ITRM20110403A1 (it) * 2011-07-28 2013-01-29 Ospedale Pediatrico Bambino Gesu Microvescicole isolate da cellule mesenchimali come agenti immunosoppressori.
US20150018227A1 (en) 2011-08-05 2015-01-15 University Of Louisville Research Foundation, Inc. Microrna biomarkers
EP2604288A1 (en) 2011-12-16 2013-06-19 Biocant - Associação De Transferência De Tecnologia Nanoparticles and uses thereof
WO2013110253A1 (de) 2011-12-23 2013-08-01 Appbyyou Gmbh Verfahren zum aufbau einer verschlüsselten verbindung zwischen zwei kommunikationsgeräten nach vorherigem schlüsselaustausch über eine kurzstreckenverbindung
US20130273544A1 (en) 2012-04-17 2013-10-17 Life Technologies Corporation Methods and compositions for exosome isolation
WO2013188832A1 (en) * 2012-06-14 2013-12-19 System Biosciences, Llc Methods for microvesicle isolation and selective removal
US9005888B2 (en) 2012-06-14 2015-04-14 System Biosciences, Llc Methods for microvesicle isolation and selective removal
EP2687219A1 (en) * 2012-07-18 2014-01-22 Universität Duisburg-Essen Use of preparations comprising exosomes derived from mesenchymal stem cells (MSCs) in the prevention and therapy of inflammatory conditions
EP3563859B1 (en) 2012-08-13 2021-10-13 Cedars-Sinai Medical Center Cardiosphere-derived exosomes for tissue regeneration
EP3415627A1 (en) 2012-11-13 2018-12-19 Codiak BioSciences, Inc. Delivery of therapeutic agent
AU2014244618A1 (en) 2013-03-13 2015-10-08 University Of Miami Method for isolation and purification of microvesicles from cell culture supernatants and biological fluids
US12558316B2 (en) 2013-03-13 2026-02-24 University Of Miami Methods and compositions for the treatment of epidermolysis bullosa
WO2016043654A1 (en) 2014-09-15 2016-03-24 Agency For Science, Technology And Research Methods of treating graft versus host disease (gvhd) or epidermolysis bullosa (eb) with exosomes
US20160220613A1 (en) 2013-09-16 2016-08-04 Agency For Science, Technology And Research Method
WO2015138878A1 (en) 2014-03-13 2015-09-17 Research Institute At Nationwide Children's Hospital, Inc. Methods of delivering heparin binding epidermal growth factor using stem cell generated exosomes
WO2016172598A1 (en) 2015-04-22 2016-10-27 The Broad Institute Inc. Exosomes and uses thereof
EP3302501B1 (en) 2015-05-29 2021-09-22 Merck Sharp & Dohme Corp. Combination of a pd-1 antagonist and cpg-c type oligonucleotide for treating cancer
WO2017123022A1 (ko) 2016-01-12 2017-07-20 주식회사 강스템바이오텍 고함량의 성장인자를 함유한 줄기세포 유래 엑소좀
US11918687B2 (en) 2016-01-15 2024-03-05 Orbsen Therapeutics Limited SDC-2 exosome compositions and methods of isolation and use
CN111182890A (zh) 2017-09-22 2020-05-19 迈阿密大学 用于治疗大疱性表皮松解症的方法和组合物
AU2021327376A1 (en) 2020-08-21 2023-04-20 University Of Miami Compositions and methods of treatment using microvesicles from bone marrow-derived mesenchymal stem cells

Similar Documents

Publication Publication Date Title
AU2022206811B2 (en) Method for isolation and purification of microvesicles from cell culture supernatants and biological fluids
CN110499287B (zh) 简易制备胎盘间充质干细胞外泌体的方法
JP7525396B2 (ja) 表皮水疱症を処置するための方法及び組成物
US12558316B2 (en) Methods and compositions for the treatment of epidermolysis bullosa
US12048719B2 (en) Acellular biologic composition and method of manufacture
HK40088378A (en) Method for isolation and purification of microvesicles from cell culture supernatants and biological fluids
CN101845093A (zh) 一种适于规模化生产的眼镜蛇蛇毒神经生长因子的纯化方法
HK40032447A (en) Method for isolation and purification of microvesicles from cell culture supernatants and biological fluids
EA047075B1 (ru) Способы и композиции для лечения буллезного эпидермолиза
CN102993325A (zh) 一种从刺参中提取糖胺聚糖的方法
HK1263117A1 (en) Human platelet lysate derived extracellular vesicles for use in medicine
CN104447943A (zh) 一种提取狗毛皮屑变应原的方法